Dr Dongli Liu

Back to

Dr Dongli Liu is a postdoctoral researcher with extensive expertise in molecular and cell biology, including patient-derived primary cell culture, and strong bioinformatics skills in next-generation sequencing (NGS). Since joining the Gynaecological Cancer Research Group at the University of New South Wales Sydney in 2018, Dr Liu has led multiple research projects aimed at identifying prognostic biomarkers and novel therapies for ovarian and endometrial cancers. Her work has also focused on developing patient-derived 3D cancer models to test novel therapies in molecular subtype of malignancies.

Phone

+61449600908

E-mail

dongli.liu@unsw.edu.au

Location

Lowy Cancer Research Centre

Journal articles | 2026

Gunther K; Liu D; Cortesi M; Powell E; Nesbitt-Hawes E; Abbott JA; Ford CE, 2026, 'Patient-derived epithelial cell organoids mimic the phenotypic complexity of endometriosis subtypes', Human Reproduction, 41, pp. 262 - 274, http://dx.doi.org/10.1093/humrep/deaf230

Journal articles | 2026

Liu D; Garikapati S; Wong-Brown M; Bowden NA; Stannard G; Hodder B; Wan KM; Xie HE; Mylvaganam G; Odgers H; Loo C; Ford CE, 2026, 'Utilisation of an integrated drug repurposing pipeline to treat ROR1 expressing endometrial cancer', International Journal of Gynecological Cancer, 36, pp. 103011 - 103011, http://dx.doi.org/10.1016/j.ijgc.2025.103011

Journal articles | 2026

Liu D; Wong-Brown M; Sarker FA; Matthews B; Morrison J; Dickson KA; Alghalayini A; Stojanova J; Wan KM; Duggan J; Loo C; Stannard G; Powell E; Hodder B; Barlow E; Marsh DJ; Ford CE; Bowden NA, 2026, 'Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer', Therapeutic Advances in Medical Oncology, 18, http://dx.doi.org/10.1177/17588359251409010

Journal articles | 2025

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Giordano E; Ford CE, 2025, 'Development and validation of a computational tool to predict treatment outcomes in cells from high-grade serous ovarian cancer patients', Bioengineering and Translational Medicine, 10, http://dx.doi.org/10.1002/btm2.70082

Journal articles | 2025

Gunther K; Fisher T; Liu D; Abbott J; Ford CE, 2025, 'Endometriosis is not the endometrium: Reviewing the over-representation of eutopic endometrium in endometriosis research', ELIFE, 14, http://dx.doi.org/10.7554/eLife.103825

Journal articles | 2025

Gunther K; Liu D; Stannard G; Holmes M; Loo C; Guo B; Bowden N; Abbott J; Ford CE, 2025, 'An integrated multimodal approach to drug repurposing in endometriosis, using ROR1 as a target', Frontiers in Pharmacology, 16, http://dx.doi.org/10.3389/fphar.2025.1716062

Journal articles | 2025

Liu D; Glubb D; O'Mara T; Ford CE, 2025, 'The Multi-Kinase Inhibitor GZD824 (Olverembatinib) Shows Pre-Clinical Efficacy in Endometrial Cancer', Cancer Medicine, 14, http://dx.doi.org/10.1002/cam4.70531

Journal articles | 2025

Liu D; Vandenberg CJ; Sini P; Waldmeier L; Baumgartinger R; Pisarsky L; Petroczi G; Ratnayake G; Scott CL; Ford CE, 2025, 'The antibody–drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models', Therapeutic Advances in Medical Oncology, 17, http://dx.doi.org/10.1177/17588359251332471

Journal articles | 2024

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford CE, 2024, 'Accurate Identification of Cancer Cells in Complex Pre-Clinical Models Using a Deep-Learning Neural Network: A Transfection-Free Approach', Advanced Biology, 8, http://dx.doi.org/10.1002/adbi.202400034

Journal articles | 2024

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford CE, 2024, 'Accurate Identification of Cancer Cells in Complex Pre‐Clinical Models Using a Deep‐Learning Neural Network: A Transfection‐Free Approach (Adv. Biology 11/2024)', Advanced Biology, 8, http://dx.doi.org/10.1002/adbi.202470112

Journal articles | 2024

Cortesi M; Liu D; Yee C; Marsh DJ; Ford CE, 2024, 'Author Correction: A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models (Scientific Reports, (2023), 13, 1, (15769), 10.1038/s41598-023-42486-3)', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-023-50403-x

Journal articles | 2024

Liu D; Powell E; Wan KM; Athavale R; Loo C; Ford CE, 2024, 'Abstract B014: Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer', Clinical Cancer Research, 30, pp. B014 - B014, http://dx.doi.org/10.1158/1557-3265.endo24-b014

Journal articles | 2024

Matthews B; Wong-Brown M; Liu D; Yee C; Dickson KA; Schneider J; Islam S; Head R; Martin JH; Ford CE; Marsh DJ; Bowden NA, 2024, 'Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer', Molecular Therapy Oncology, 32, http://dx.doi.org/10.1016/j.omton.2024.200911

Journal articles | 2023

Cortesi M; Liu D; Yee C; Marsh DJ; Ford CE, 2023, 'A comparative analysis of 2D and 3D experimental data for the identification of the parameters of computational models', Scientific Reports, 13, http://dx.doi.org/10.1038/s41598-023-42486-3

Journal articles | 2023

Fivelman B; Liu D; Ford C; Wan KM; Loo C, 2023, 'Mixed large cell neuroendocrine carcinoma and high grade serous carcinoma of the ovary: a histopathological case report', Pathology, 55, pp. S55 - S55, http://dx.doi.org/10.1016/j.pathol.2022.12.178

Journal articles | 2022

Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2022, 'Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target (Scientific Reports, (2020), 10, 1, (13906), 10.1038/s41598-020-70924-z)', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-15043-7

Journal articles | 2022

Liu D; Kaufmann GF; Breitmeyer JB; Dickson KA; Marsh DJ; Ford CE, 2022, 'The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells', Pharmaceutics, 14, http://dx.doi.org/10.3390/pharmaceutics14040837

Journal articles | 2021

Joshi N; Liu D; Dickson KA; Marsh DJ; Ford CE; Stenzel MH, 2021, 'An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles', Journal of Materials Chemistry B, 9, pp. 9123 - 9135, http://dx.doi.org/10.1039/d1tb01837j

Journal articles | 2021

Liu D; Enriquez L; Ford CE, 2021, 'Ror2 is epigenetically regulated in endometrial cancer', Cancers, 13, pp. 1 - 16, http://dx.doi.org/10.3390/cancers13030383

Journal articles | 2021

Liu D; Sharbeen G; Phillips P; Johns AL; Gill AJ; Chantrill LA; Timpson P; Chou A; Pajic M; Dwarte T; Herrmann D; Vennin C; Cox TR; Pereira B; Ritchie S; Reed DA; Chambers CR; Metcalf X; Nobis M; Waddell N; Pearson JV; Patch AM; Nones K; Newell F; Mukhopadhyay P; Addala V; Kazakoff S; Holmes O; Leonard C; Wood S; Grimmond SM; Hofmann O; Samra JS; Pavlakis N; Arena J; High HA; Asghari R; Merrett ND; Das A; Cosman PH; Ismail K; Stoita A; Williams D; Spigellman A; Lam VW; McLeod D; Kirk J; Kench JG; Grimison P; Sandroussi C; Goodwin A; Mead RS; Tucker K; Andrews L; Texler M; Forrest C; Ballal M; Fletcher D; Beilin M; Feeney K; Epari K; Mukhedkar S; Zeps N; Nguyen NQ; Ruszkiewicz AR; Worthley C; Chen J; Brooke-Smith ME; Papangelis V; Clouston AD; Barbour AP; O’Rourke TJ; Fawcett JW; Slater K; Hatzifotis M; Hodgkinson P; Nikfarjam M; Eshleman JR; Hruban RH; Wolfgang CL; Scarpa A; Lawlor RT; Corbo V; Bassi C; Biankin AV; Jamieson NB; Chang DK; Dreyer SB; Ford CE, 2021, 'ROR1 and ROR2 expression in pancreatic cancer', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08952-9

Journal articles | 2021

Werner B; Yuwono N; Duggan J; Liu D; David C; Srirangan S; Provan P; DeFazio A; Arora V; Farrell R; Lee YC; Warton K; Ford C, 2021, 'Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer', Gynecologic Oncology, 162, pp. 720 - 727, http://dx.doi.org/10.1016/j.ygyno.2021.06.028

Journal articles | 2020

Liu D; Gunther K; Enriquez LA; Daniels B; O’Mara TA; Tang K; Spurdle AB; Ford CE, 2020, 'ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-020-70924-z

Journal articles | 2019

Costanzo A; Liu D; Nowson C; Duesing K; Archer N; Bowe S; Keast R, 2019, 'A low-fat diet up-regulates expression of fatty acid taste receptor gene FFAR4 in fungiform papillae in humans: a co-twin randomised controlled trial', British Journal of Nutrition, 122, pp. 1212 - 1220, http://dx.doi.org/10.1017/S0007114519002368

Journal articles | 2018

Liu D; Costanzo A; Evans MDM; Archer NS; Nowson C; Duesing K; Keast R, 2018, 'Expression of the candidate fat taste receptors in human fungiform papillae and the association with fat taste function', British Journal of Nutrition, 120, pp. 64 - 73, http://dx.doi.org/10.1017/S0007114518001265

Journal articles | 2016

Archer NS; Liu D; Shaw J; Hannan G; Duesing K; Keast R, 2016, 'A comparison of collection techniques for gene expression analysis of human oral taste tissue', Plos One, 11, http://dx.doi.org/10.1371/journal.pone.0152157

Journal articles | 2016

Liu D; Archer N; Duesing K; Hannan G; Keast R, 2016, 'Mechanism of fat taste perception: Association with diet and obesity', Progress in Lipid Research, 63, pp. 41 - 49, http://dx.doi.org/10.1016/j.plipres.2016.03.002
Preprints | 2024

Cortesi M; Li J; Liu D; Guo T; Dokos S; Warton K; Ford C, 2024, A novel approach for the quantification of single-cell adhesion dynamics from microscopy images, http://dx.doi.org/10.1101/2024.10.08.616409

Preprints | 2024

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Giordano E; Ford C, 2024, Development and validation of a computational tool to predict treatment outcomes in cells from High-Grade Serous Ovarian Cancer patients, http://dx.doi.org/10.1101/2024.10.02.616212

Preprints | 2023

Cortesi M; Liu D; Powell E; Barlow E; Warton K; Ford C, 2023, Accurate identification of cancer cells in complex pre-clinical models using deep-learning: a transfection-free approach, http://dx.doi.org/10.1101/2023.10.15.562411

Preprints | 2023

Cortesi M; Liu D; Yee C; Marsh D; Ford C, 2023, Model Parameter identification using 2D vs 3D experimental data: a comparative analysis, http://dx.doi.org/10.1101/2023.05.17.541071

Conference Abstracts | 2023

Liu D; Powell E; Wan KM; Athavale R; Loo C; Ford CE, 2023, 'Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 30, presented at AACR Special Conference on Endometrial Cancer - Transforming Care through Science, MA, Boston, 16 November 2023 - 18 November 2023, http://dx.doi.org/10.1158/1557-3265.ENDO24-B014

Preprints | 2023

Matthews B; Wong-Brown M; Liu D; Yee C; Dickson K-A; Schneider J; Islam S; Head R; Martin J; Ford C; Marsh D; Bowden N, 2023, Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer, http://dx.doi.org/10.22541/au.169580899.90269470/v1

Conference Papers | 2021

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2021, 'Abstract PO042: ROR2 is epigenetically regulated in endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. PO042 - PO042, http://dx.doi.org/10.1158/1557-3265.endomet20-po042

Conference Papers | 2021

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Abstract 1062: Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody', in Cancer Research, American Association for Cancer Research (AACR), pp. 1062 - 1062, http://dx.doi.org/10.1158/1538-7445.am2021-1062

Conference Papers | 2021

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, PA, Philadelphia, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), PA, Philadelphia, 10 April 2021 - 21 May 2021

Conference Abstracts | 2020

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR2 is epigenetically regulated in endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 27, presented at AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, ELECTR NETWORK, 09 November 2020 - 10 November 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000617951200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts | 2020

Liu D; Gunther K; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR1: A novel target in endometrial cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-2942

Conference Papers | 2020

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2020, 'Abstract A41: ROR1 is associated with ovarian cancer progression and chemoresistance', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. A41 - A41, http://dx.doi.org/10.1158/1557-3265.ovca19-a41

Conference Abstracts | 2019

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2019, 'ROR1 is associated with ovarian cancer progression and chemoresistance.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 59 - 60, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2016

Liu D; Archer N; Duesing K; Keast R, 2016, 'Expression of Candidate Fat Taste Receptors in Human Fungiform Papillae', in CHEMICAL SENSES, OXFORD UNIV PRESS, FL, Bonita Springs, pp. E32 - E32, presented at 38th Annual Meeting of the Association-for-Chemoreception-Sciences (AChemS), FL, Bonita Springs, 20 April 2016 - 23 April 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383854300081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

2024 UNSW 3Rs grant;

Endometriosis Australia 2021 project grant;

2022 MAZDA Foundation and Australian Gynaecological Cancer Foundation grant;

2023 UNSW EMCR seed grant;

2022 UNSW Medicine ECAN-Ramaciotti Centre ECR grant.

2025 WHRTN Emerging Leaders Fellowship Program Scholarship;

2023 ANZGOG Annual Scientific Meeting Best Poster Award, Brisbane;

2022 ANZGOG Annual Scientific Meeting 2022 Abstract Award, Melbourne;

2017 GEDDA AWARD by the 16th International Congress on Twin Studies Madrid, Spain;

2016 Chinese Government Award for Outstanding Self-financed Students Abroad.

My Research Supervision

Nadia Kuepper (PhD student)

Hayley Sperinde (PhD student)

Nicole Matysiak (PhD student)

Sumyukta Garikapati (PhD student)

Kate Gunther (PhD student, completed 2026)

Aarya Tickoo (Honours student, completed 2024)

Kaitlyn Trajcevski (Honours student, completed 2023)

Sophie Hay (Honours student, completed 2022)

Kirsty Brodbeck (ILP student, completed 2023)

Luis Enriquez (Honours student, completed 2020)

Kate Gunther (Honours student, complete 2020)

My Teaching

E-mentor for for PATH3205 Molecular Basis of Disease;

Facilitator for scenario groups of MFAC1527 Society and Health.

Follow

Dr Dongli Liu

Follow me